External Validation of 3 Prediction Models for Mortality in Out-of-Hospital Cardiac Arrest Survivors: A Retrospective Multicenter Study

院外心脏骤停幸存者死亡率预测模型的外部验证:一项回顾性多中心研究

阅读:2

Abstract

BACKGROUND: Predictive models such as the Cardiac Arrest Survival Score (CASS), FACTOR score, and Survival After ROSC in Cardiac Arrest (SARICA) have been developed to estimate in-hospital mortality in out-of-hospital cardiac arrest survivors. This study aims to externally validate and compare their predictive performance to determine their clinical utility upon emergency department admission. METHODS: This retrospective multicenter cohort study included out-of-hospital cardiac arrest patients admitted to the National Taiwan University Hospital and its branches between January 2016 and March 2024. The outcome was in-hospital mortality following intensive care unit admission. We assessed the CASS, FACTOR, and a modified SARICA (mSARICA) score using the area under the receiver operating characteristic curve, positive predictive value, and negative predictive value. The SARICA score was adapted into the mSARICA score to ensure outcome consistency. The positive predictive value threshold was set at 0.85 to minimize false-positive predictions. RESULTS: The study included 1456 patients, of whom 495 (34%) survived to discharge and 961 (66%) died before discharge. The area under the receiver operating characteristics for CASS, FACTOR, and mSARICA were 0.684 (95% CI, 0.654-0.713), 0.677 (95% CI, 0.647-0.706), and 0.711 (95% CI, 0.682-0.739), respectively, with no significant differences among them. The optimal cutoff values were >17.5 for CASS, ≥69.25 for FACTOR, and <1.0 for mSARICA. While CASS and FACTOR demonstrated similar sensitivity, specificity, and negative predictive value, mSARICA exhibited significantly higher sensitivity, lower specificity, and higher negative predictive value. CONCLUSIONS: All scores demonstrated fair but not excellent discrimination for in-hospital mortality. When minimizing false positives is critical, CASS and FACTOR may be preferable, whereas mSARICA offers greater sensitivity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。